126 related articles for article (PubMed ID: 9184782)
21. Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases.
Robert ME; Skacel M; Ullman T; Bernstein CN; Easley K; Goldblum JR
Am J Clin Pathol; 2004 Jul; 122(1):94-9. PubMed ID: 15272536
[TBL] [Abstract][Full Text] [Related]
22. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis.
Markowitz J; Kahn E; Grancher K; Hyams J; Treem W; Daum F
Am J Gastroenterol; 1993 Dec; 88(12):2034-7. PubMed ID: 8249970
[TBL] [Abstract][Full Text] [Related]
23. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
24. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
Kilias D; Macrae FA; Sharpe K; Young GP
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
[TBL] [Abstract][Full Text] [Related]
25. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies.
Paspatis GA; Zizi A; Chlouverakis GJ; Giannikaki ES; Vasilakaki T; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Sep; 93(9):1472-7. PubMed ID: 9732928
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
27. Increased proliferation of middle to distal colonic cells during colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Kuramoto T; Ishida K; Kawakami K; Abe Y; Morita E; Murano N; Toshina K; Nishikawa T; Maemura K; Shimamoto C; Hirata I; Katsu K; Higuchi K
Oncol Rep; 2007 Dec; 18(6):1457-62. PubMed ID: 17982630
[TBL] [Abstract][Full Text] [Related]
28. [The influence of Candida albicans on the course of ulcerative colitis].
Zwolińska-Wcisło M; Budak A; Trojanowska D; Mach T; Rudnicka-Sosin L; Galicka-Latała D; Nowak P; Cibor D
Przegl Lek; 2006; 63(7):533-8. PubMed ID: 17203803
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis.
del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J
Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954
[TBL] [Abstract][Full Text] [Related]
30. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
[TBL] [Abstract][Full Text] [Related]
31. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine.
Pironi L; Cornia GL; Ursitti MA; Dallasta MA; Miniero R; Fasano F; Miglioli M; Barbara L
Int J Clin Pharmacol Res; 1988; 8(2):143-8. PubMed ID: 2897953
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Abe Y; Morita E; Murano N; Yasumoto S; Toshina K; Nishikawa T; Maemura K; Hirata I; Katsu K
J Gastroenterol Hepatol; 2007 Sep; 22(9):1474-81. PubMed ID: 17716351
[TBL] [Abstract][Full Text] [Related]
34. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis.
Elkowitz D; Daum F; Markowitz J; Proccaccino J; Boas E; Cuomo J; Kahn E
Ann Clin Lab Sci; 2004; 34(2):143-9. PubMed ID: 15228225
[TBL] [Abstract][Full Text] [Related]
36. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
[TBL] [Abstract][Full Text] [Related]
37. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
[TBL] [Abstract][Full Text] [Related]
39. Significance of increased proliferation of immature plasma cells in the appendix of patients with ulcerative colitis.
Kawachiya T; Oshitani N; Jinno Y; Watanabe K; Nakamura S; Fujiwara Y; Higuchi K; Maeda K; Nishiguchi Y; Hirakawa K; Matsumoto T; Arakawa T
Int J Mol Med; 2005 Mar; 15(3):417-23. PubMed ID: 15702231
[TBL] [Abstract][Full Text] [Related]
40. Effects of milk and milk products on rectal mucosal cell proliferation in humans.
Karagas MR; Tosteson TD; Greenberg ER; Rothstein RI; Roebuck BD; Herrin M; Ahnen D
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):757-66. PubMed ID: 9752983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
